US Stock MarketDetailed Quotes
CLSD Clearside Biomedical
- 1.279
- -0.001-0.05%
Trading May 8 15:54 ET
95.61MMarket Cap-2413P/E (TTM)
1.335High1.250Low159.78KVolume1.280Open1.280Pre Close204.87KTurnover0.23%Turnover RatioLossP/E (Static)74.73MShares2.12052wk High-6.01P/B88.48MFloat Cap0.65052wk Low--Dividend TTM69.16MShs Float25.080Historical High--Div YieldTTM6.67%Amplitude0.560Historical Low1.282Avg Price1Lot Size
About Clearside Biomedical Company
Clearside Biomedical, Inc. is a biopharmaceutical company, which delivers therapies to the back of the eye through the suprachoroidal space. Its pipeline include CLS-AX, Integrin Inhibitor, and gene therapy. The company was founded by Samir Kumar Patel, Vladimir Zarnitsyn, Mark Prausnitz, Daniel H. White, and Henry F. Edelhauser in May 2011 and is headquartered in Alpharetta, GA.
Company Profile
SymbolCLSD
Company NameClearside Biomedical
Listing DateJun 2, 2016
Issue Price7.00
Founded2011
CEODr. George Lasezkay, J.D.,Pharm.D.
MarketNASDAQ
Employees30
Securities TypeOrdinary Shares
Fiscal Year Ends12-31
Address900 North Point Parkway,Suite 200
CityAlpharetta
ProvinceGeorgia
CountryUnited States of America
Zip Code30005
Phone1-678-270-3631
Websitehttp://www.clearsidebio.com
Company Executives
- Name
- Position
- Salary
- Dr. George Lasezkay, J.D.,Pharm.D.
- President, Chief Executive Officer and Director
- 1.54M
- Victor Chong, M.D.
- Chief Medical Officer
- --
- Charles A. Deignan
- Chief Financial Officer and Principal Accounting Officer
- 854.41K
- William D. Humphries
- Chairman of the Board
- 91.71K
- Anthony S. Gibney
- Director
- --
- Clay B. Thorp
- Independent Director
- 96.08K
- Dr. Christy L. Shaffer,PhD
- Independent Director
- 86.08K
- Dr. Nancy J. Hutson, PhD
- Independent Director
- 85.46K
- Richard J. Croarkin
- Independent Director
- 91.08K
- Jeffrey L. Edwards
- Independent Director
- 88.58K
- Dr. Benjamin R. Yerxa,PhD
- Independent Director
- 88.58K
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
%Chg